Aer Therapeutics CEO Jim Shaffer (L) and founder John Fahy
April 13, 2023 07:00 AM EDT
Financing
Startups

Trio of VCs launch­es Gael­ic-in­spired Aer Ther­a­peu­tics with $36M to prove it­self in COPD around 2025

Kyle LaHucik

Senior Reporter

North Car­oli­na biotech Aer Ther­a­peu­tics emerged Thurs­day with $36 mil­lion in ven­ture cap­i­tal fund­ing to run a Phase I study in Aus­tralia this year and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times